Get started
AMGEN DRNAMGEN DRNAMGEN DRN

AMGEN DRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AMGN34 chart


Full chart

Key facts today

Jefferies has maintained a Buy rating on Amgen Inc. (AMGN) and set a price target of $380.00 per share.
Amgen was the worst performer on the Dow and the Nasdaq, and among the worst on the S&P 500, down 7.1%.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪998.17 B‬ BRL
Dividend yield (indicated)
1.87%
Price to earnings Ratio (TTM)
44,153.33
Basic EPS (TTM)
0.00 BRL
Net income (FY)
‪33.55 B‬ BRL
Revenue (FY)
‪139.91 B‬ BRL
Shares float
—
Beta (1Y)
−0.13

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
BRAMGNBDR004
FIGI
BBG002H1H201
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AMGN34 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGN34 highest yielding bonds


AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
6.16%
Maturity date
Apr 1, 2097
US31162BP4
AMGEN 12/43
Yield to maturity
5.90%
Maturity date
May 15, 2043
US31162DU1
AMGEN 23/63
Yield to maturity
5.67%
Maturity date
Mar 2, 2063
AMGN.GV
Amgen Inc. 6.4% 01-FEB-2039
Yield to maturity
5.65%
Maturity date
Feb 1, 2039
US31162DT4
AMGEN 23/53
Yield to maturity
5.58%
Maturity date
Mar 2, 2053
US31162DS6
AMGEN 23/43
Yield to maturity
5.56%
Maturity date
Mar 2, 2043
AMGN.GY
Amgen Inc. 5.75% 15-MAR-2040
Yield to maturity
5.55%
Maturity date
Mar 15, 2040
US31162DN7
AMGEN 23/26
Yield to maturity
5.55%
Maturity date
Mar 2, 2026
US31162BH2
AMGEN 2042
Yield to maturity
5.54%
Maturity date
Jun 15, 2042
AMGN.HG
Amgen Inc. 5.15% 15-NOV-2041
Yield to maturity
5.51%
Maturity date
Nov 15, 2041
US31162DK3
AMGEN 22/53
Yield to maturity
5.50%
Maturity date
Mar 1, 2053

Explore more bonds 

Sparks


Curated watchlists where AMGN34 is featured.

See all sparks